ArticleJBMR plus2026
An ex vivo appositional growth model to study periosteal activity and associated BMP signaling.
Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The periosteum is an osteogenic tissue containing periosteal stem and progenitor cells (PSPCs) that form and repair bones. Much is known about how the periosteum regulates fracture repair, but its key role in bone accrual during postnatal growth and adult load-induced formation remains a significant knowledge gap. The periosteal activity that drives bone formation and repair can be studied using existing mouse models, but traditional in vivo techniques are not feasible for investigating appositional growth, or widening of the bones, in young mouse pups. We therefore developed an ex vivo appositional growth model that combines existing in vitro fluid flow approaches and a custom support to secure mouse femur explants in a culture system. We observed that femurs widen after daily exposure to fluid flow, and this coincides with expansion of the periosteum and activation of BMP signaling, which is essential for periosteal osteogenesis. We further validated our system by recapitulating an in vivo thin-bone phenotype in mice that exhibit a lack of periosteal activity due to disrupted BMP signaling. Using our device, we were able to partially recover the thin-bone phenotype by supplementing culture media with recombinant BMP2. This ex vivo appositional growth model is an important step in obtaining a more holistic understanding of how the periosteum and its resident PSPCs drive bone formation and repair. Furthermore, we anticipate this apparatus can be used to interrogate the periosteum's osteogenic capabilities and motivate future bone anabolism treatments for skeletal diseases and the prevention of fractures or enhancement of repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.